| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Proquest Investments Iv, L.P. is a 10% Owner at UroGen Pharma Ltd. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 39 sells.
Estimated insider holdings value: $38.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2017 | URGN Urogen Pharma Ltd. | 10% Owner | Sell | 209,298 | $40.60 | $8,497,871.49 | -7.3% | |
| Apr 25, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sale+OE | 54,180 | $88.38 | $4,788,481.95 | -76.6% | |
| Apr 3, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 91,332 | $83.09 | $7,589,014.38 | -0.8% | |
| Mar 29, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 106,468 | $83.01 | $8,837,576.19 | -0.9% | |
| Mar 23, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 1,200 | $83.05 | $99,657.00 | - | |
| Mar 20, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 100,000 | $82.06 | $8,206,307.87 | -0.9% | |
| Jan 4, 2017 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 65,114 | $85.16 | $5,545,108.24 | -1.7% | |
| Nov 11, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 34,486 | $85.15 | $2,936,604.80 | -0.2% | |
| Nov 9, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 153,830 | $79.29 | $12,197,276.85 | -0.5% | |
| Nov 4, 2016 | EGRX Eagle Pharmaceuticals, Inc. | 10% Owner | Sell | 245,770 | $71.02 | $17,455,384.89 | -1.9% |